134 related articles for article (PubMed ID: 17273781)
21. A novel tumor suppressor, REIC/Dkk-3 gene identified by our in vitro transformation model of normal human fibroblasts works as a potent therapeutic anti-tumor agent.
Sakaguchi M; Huh NH; Namba M
Adv Exp Med Biol; 2011; 720():209-15. PubMed ID: 21901630
[TBL] [Abstract][Full Text] [Related]
22. A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy.
Oka T; Kurozumi K; Shimazu Y; Ichikawa T; Ishida J; Otani Y; Shimizu T; Tomita Y; Sakaguchi M; Watanabe M; Nasu Y; Kumon H; Date I
Sci Rep; 2016 Sep; 6():33319. PubMed ID: 27625116
[TBL] [Abstract][Full Text] [Related]
23. Promising Gene Therapy Using an Adenovirus Vector Carrying REIC/Dkk-3 Gene for the Treatment of Biliary Cancer.
Tanaka E; Uchida D; Shiraha H; Kato H; Ohyama A; Iwamuro M; Watanabe M; Kumon H; Okada H
Curr Gene Ther; 2020; 20(1):64-70. PubMed ID: 32148193
[TBL] [Abstract][Full Text] [Related]
24. An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis.
Abarzua F; Kashiwakura Y; Takaoka M; Watanabe M; Ochiai K; Sakaguchi M; Iwawaki T; Tanimoto R; Nasu Y; Huh NH; Kumon H
Biochem Biophys Res Commun; 2008 Oct; 375(4):614-8. PubMed ID: 18727918
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7.
Sakaguchi M; Kataoka K; Abarzua F; Tanimoto R; Watanabe M; Murata H; Than SS; Kurose K; Kashiwakura Y; Ochiai K; Nasu Y; Kumon H; Huh NH
J Biol Chem; 2009 May; 284(21):14236-44. PubMed ID: 19279003
[TBL] [Abstract][Full Text] [Related]
26. Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy for prostate cancer.
Kawauchi K; Watanabe M; Kaku H; Huang P; Sasaki K; Sakaguchi M; Ochiai K; Huh NH; Nasu Y; Kumon H
Acta Med Okayama; 2012; 66(1):7-16. PubMed ID: 22358134
[TBL] [Abstract][Full Text] [Related]
27. A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.
Watanabe M; Sakaguchi M; Kinoshita R; Kaku H; Ariyoshi Y; Ueki H; Tanimoto R; Ebara S; Ochiai K; Futami J; Li SA; Huang P; Nasu Y; Huh NH; Kumon H
Oncol Rep; 2014 Mar; 31(3):1089-95. PubMed ID: 24398705
[TBL] [Abstract][Full Text] [Related]
28. Internalization of REIC/Dkk-3 protein by induced pluripotent stem cell-derived embryoid bodies and extra-embryonic tissues.
Kataoka K; Sakaguchi M; Li KP; Taketa C; Yamamoto K; Du G; Funahashi H; Murata H; Huh NH
Int J Mol Med; 2010 Dec; 26(6):853-9. PubMed ID: 21042779
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.
Ochiai K; Morimatsu M; Kato Y; Ishiguro-Oonuma T; Udagawa C; Rungsuriyawiboon O; Azakami D; Michishita M; Ariyoshi Y; Ueki H; Nasu Y; Kumon H; Watanabe M; Omi T
Oncotarget; 2016 Jan; 7(3):3283-96. PubMed ID: 26658102
[TBL] [Abstract][Full Text] [Related]
30. Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis.
Hattori Y; Kurozumi K; Otani Y; Uneda A; Tsuboi N; Makino K; Hirano S; Fujii K; Tomita Y; Oka T; Matsumoto Y; Shimazu Y; Michiue H; Kumon H; Date I
PLoS One; 2022; 17(8):e0273242. PubMed ID: 36006934
[TBL] [Abstract][Full Text] [Related]
31. Properties of the feline tumour suppressor reduced expression in immortalized cells (REIC/Dkk-3).
Ochiai K; Oda H; Shono S; Kato Y; Sugihara S; Nakazawa S; Azakami D; Michishita M; Onozawa E; Bonkobara M; Sako T; Shun-Ai L; Ueki H; Watanabe M; Omi T
Vet Comp Oncol; 2017 Dec; 15(4):1181-1186. PubMed ID: 27353749
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review).
Watanabe M; Nasu Y; Kumon H
Oncol Lett; 2014 Mar; 7(3):595-601. PubMed ID: 24527065
[TBL] [Abstract][Full Text] [Related]
33. The expression pattern and functional role of REIC/Dkk-3 in the development of cutaneous squamous cell carcinoma.
Shin JM; Choi DK; Kang HY; Sohn KC; Lee Y; Kim CD; Lee JH; Park BC
J Dermatol Sci; 2016 Oct; 84(1):88-96. PubMed ID: 27354306
[TBL] [Abstract][Full Text] [Related]
34. Expression of REIC/Dkk-3 in normal and hyperproliferative epidermis.
Du G; Kataoka K; Sakaguchi M; Abarzua F; Than SS; Sonegawa H; Makino T; Shimizu T; Huh NH
Exp Dermatol; 2011 Mar; 20(3):273-7. PubMed ID: 21323747
[TBL] [Abstract][Full Text] [Related]
35. Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development.
Zhang K; Watanabe M; Kashiwakura Y; Li SA; Edamura K; Huang P; Yamaguchi K; Nasu Y; Kobayashi Y; Sakaguchi M; Ochiai K; Yamada H; Takei K; Ueki H; Huh NH; Li M; Kaku H; Na Y; Kumon H
Int J Oncol; 2010 Dec; 37(6):1495-501. PubMed ID: 21042718
[TBL] [Abstract][Full Text] [Related]
36. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.
Chen J; Watanabe M; Huang P; Sakaguchi M; Ochiai K; Nasu Y; Ouchida M; Huh NH; Shimizu K; Kashiwakura Y; Kaku H; Kumon H
Int J Mol Med; 2009 Dec; 24(6):789-94. PubMed ID: 19885619
[TBL] [Abstract][Full Text] [Related]
37. Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas.
Tsuji T; Nozaki I; Miyazaki M; Sakaguchi M; Pu H; Hamazaki Y; Iijima O; Namba M
Biochem Biophys Res Commun; 2001 Nov; 289(1):257-63. PubMed ID: 11708809
[TBL] [Abstract][Full Text] [Related]
38. Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1.
Ochiai K; Watanabe M; Ueki H; Huang P; Fujii Y; Nasu Y; Noguchi H; Hirata T; Sakaguchi M; Huh NH; Kashiwakura Y; Kaku H; Kumon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):391-5. PubMed ID: 21835165
[TBL] [Abstract][Full Text] [Related]
39. Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies.
Suzawa K; Shien K; Peng H; Sakaguchi M; Watanabe M; Hashida S; Maki Y; Yamamoto H; Tomida S; Soh J; Asano H; Tsukuda K; Nasu Y; Kumon H; Miyoshi S; Toyooka S
Anticancer Res; 2017 Jan; 37(1):301-307. PubMed ID: 28011506
[TBL] [Abstract][Full Text] [Related]
40. REIC/Dkk-3 induces cell death in human malignant glioma.
Mizobuchi Y; Matsuzaki K; Kuwayama K; Kitazato K; Mure H; Kageji T; Nagahiro S
Neuro Oncol; 2008 Jun; 10(3):244-53. PubMed ID: 18443132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
